Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levesque

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
Journal for Immunotherapy of Cancer|December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapyRoberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Bimodular auxin response controls organogenesis in ArabidopsisIve De Smet, Steffen Lau, Ute Voss, et al.
Bioinformatics (Oxford, England)|October 3, 2017
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysisJochen Singer, Hans-Joachim Ruscheweyh, Ariane L Hofmann, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Molecular Cancer Research : MCR|June 24, 2020
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma GrowthIkrame Lazar, Bertrand Fabre, Yongmei Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cellsEmmanuella Guenova, Yuliya Skabytska, Wolfram Hoetzenecker, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
Journal for Immunotherapy of Cancer|December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapyRoberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Bimodular auxin response controls organogenesis in ArabidopsisIve De Smet, Steffen Lau, Ute Voss, et al.
Bioinformatics (Oxford, England)|October 3, 2017
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysisJochen Singer, Hans-Joachim Ruscheweyh, Ariane L Hofmann, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Molecular Cancer Research : MCR|June 24, 2020
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma GrowthIkrame Lazar, Bertrand Fabre, Yongmei Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cellsEmmanuella Guenova, Yuliya Skabytska, Wolfram Hoetzenecker, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Pageof 29